GeminIQ Website Logo

Viewing LMAT free

Subscribe for full history, 90+ metrics, screener, watchlist...

LEMAITRE VASCULAR INC

LMAT

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets Current
Cash And Cash Equivalents At Carrying Value
272728252725262122272418
Available For Sale Securities Debt Securities Curr…
35034033131829227727410391828179
Accounts Receivable Net Current
363634323735303231302524
Prepaid Expense And Other Assets Current
645665765465
Assets Current
488478468452430408402227213203195182
Property Plant And Equipment Net
302927262525252423222221
Operating Lease Right Of Use Asset
202016161716171717181816
Goodwill
666666666666666666666666
Intangible Assets Net Excluding Goodwill
313233323334363739404243
Deferred Income Tax Assets Net
111111111112
Other Assets Noncurrent
555555544443
Assets
641630616598578556552377363354347334
Liabilities Current
Accounts Payable Current
344352222344
Accrued Liabilities Current
232529272320252321212422
Operating Lease Liability Current
333333333323
Liabilities Current
303336333125312925273029
Convertible Debt Noncurrent
169169169168168168168---0-
Operating Lease Liability Noncurrent
181814141515151616161714
Deferred Income Tax Liabilities Net
222200000000
Other Liabilities Noncurrent
111111112222
Liabilities
2202232222192152082154644454945
Stockholders Equity
Preferred Stock Value
00-000000000
Common Stock Value
000000000000
Additional Paid In Capital Common Stock
236233228224221217214211209206201198
Retained Earnings Accumulated Deficit
206195185174161152145138130122115110
Accumulated Other Comprehensive Income Loss Net Of…
-4-4-2-3-3-5-6-3-5-6-5-7
Treasury Stock Common Value
-18-18-17-16-16-16-16-14-14-14--13
Treasury Stock Value
-------16----14-
Stockholders Equity
420407394379363348337331320309298289
Liabilities And Stockholders Equity
641630616598578556552377363354347334
Allowance For Doubtful Accounts Receivable Current
111111111111
Preferred Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Preferred Stock Shares Authorized
333333333333
Preferred Stock Shares Issued
000---0-----
Preferred Stock Shares Outstanding
000000000000
Common Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized
373737373737373737373737
Common Stock Shares Issued
242424242424242424242424
Shares Outstanding
232323---23-----
Treasury Stock Common Shares
222222222222

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-13.91%-13.00%-13.06%---------
20251.10%1.56%1.39%2.51%-9.51%-4.11%-4.24%-3.28%-2.77%-6.28%0.82%-14.21%
20243.83%8.30%12.97%9.09%10.80%3.47%2.79%-10.81%-6.92%-8.88%-5.83%-7.26%
2023---2.12%-4.37%-16.80%9.04%14.98%14.69%-4.86%-9.41%12.57%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
16.31
14.32
12.89
13.58
13.96
16.49
13.14
7.74
8.36
7.57
6.51
6.28
Quick Ratio
16.12
14.20
12.75
13.41
13.77
16.31
12.90
7.54
8.16
7.43
6.30
6.10
Working Capital
458.36M
444.45M
431.91M
418.74M
399.31M
383.37M
371.59M
197.77M
187.37M
176.15M
164.72M
153.16M
Leverage & Debt
Debt to Equity
0.52
0.55
0.56
0.58
0.59
0.60
0.64
0.14
0.14
0.15
0.16
0.16
Interest Coverage TTM
14.88
14.07
13.10
15.14
19.60
35.46
254.91
-
-
-
-
-
Debt Ratio
0.34
0.35
0.36
0.37
0.37
0.37
0.39
0.12
0.12
0.13
0.14
0.14
Efficiency & Turnover
Asset Turnover TTM
0.43
0.43
0.43
0.49
0.50
0.50
0.49
0.60
0.60
0.60
0.59
0.58
Days Sales Outstanding TTM
50.22
50.48
46.56
49.01
52.39
52.71
45.76
48.10
50.79
50.76
44.43
43.25
Receivables Turnover TTM
7.27
7.23
7.84
7.45
6.97
6.92
7.98
7.59
7.19
7.19
8.22
8.44
Per Share Metrics
Diluted EPS TTM
2.68
2.71
2.52
2.19
2.06
1.97
1.93
1.81
1.66
1.50
1.34
1.21
Free Cash Flow Per Share TTM
3.23
3.47
3.29
2.92
2.31
1.82
1.66
1.49
1.41
1.48
1.33
1.03
Dividend Per Share TTM
0.90
0.85
0.80
0.76
0.72
0.68
0.64
0.62
0.60
0.58
0.56
0.54
Margin Metrics
Gross Profit Margin TTM
72.90%
72.39%
71.53%
70.97%
69.11%
68.80%
68.63%
68.34%
67.70%
66.45%
65.66%
64.58%
Operating Profit Margin TTM
29.46%
28.51%
27.21%
25.71%
23.34%
23.43%
23.77%
23.29%
22.20%
20.37%
18.97%
18.04%
Net Profit Margin TTM
25.02%
24.35%
23.13%
22.14%
20.08%
19.96%
20.03%
19.40%
18.32%
16.99%
15.56%
14.69%
Growth Metrics
Net Revenue Growth (1Y)
11.85%
13.27%
13.53%
13.07%
14.11%
13.19%
13.63%
14.81%
16.06%
18.16%
19.69%
15.83%
Net Income Growth (1Y)
39.39%
38.17%
31.10%
29.08%
25.04%
33.02%
46.28%
51.53%
49.40%
64.51%
45.89%
28.72%
EPS Growth (1Y)
37.90%
36.77%
30.02%
28.04%
24.18%
31.81%
44.75%
50.10%
47.77%
62.64%
44.30%
27.10%
Valuation Metrics
P/E TTM
33.30
39.67
31.55
36.81
39.38
41.32
46.18
49.60
48.04
42.74
40.85
43.27
P/B TTM
5.20
6.09
4.63
5.18
5.12
5.37
6.03
6.19
5.67
4.70
4.13
4.09
P/S TTM
8.33
9.66
7.30
8.15
7.91
8.25
9.25
9.62
8.80
7.26
6.36
6.36
Market Cap
2.19B
2.48B
1.82B
1.96B
1.86B
1.87B
2.03B
2.05B
1.81B
1.45B
1.23B
1.18B
Enterprise Value
2.33B
2.62B
1.96B
2.11B
2.00B
2.01B
2.18B
2.03B
1.79B
1.42B
1.21B
1.16B
Calculated Values
Free Cash Flow TTM
73.83M
79.12M
74.47M
66.23M
52.32M
41.12M
37.16M
33.49M
31.69M
33.04M
29.49M
22.84M
Net Debt
142.47M
142.02M
140.40M
142.93M
141.03M
142.64M
142.16M
-21.00M
-22.27M
-26.60M
-24.27M
-18.05M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-05-08Sale
Owner: Kamke, Trent G
Title: Senior V. P., Operations
Shares: 2,928
Price/Share: $107.00
Value: $313,296.00
Shares Owned: 3,749
Relationship: Officer
Ownership: Direct
2026-05-08Sale
Owner: Lemaitre, George W
Title: Chairman and CEO
Shares: 27,881
Price/Share: $108.69
Value: $3,030,385.89
Shares Owned: 1,430,019
Relationship: Director,Officer
Ownership: Direct
2026-05-07Sale
Owner: Jasinski, Lawrence J
Title: -
Shares: 3,943
Price/Share: $110.00
Value: $433,730.00
Shares Owned: 4,714
Relationship: Director
Ownership: Direct
2026-05-07Sale
Owner: Ross, Bridget A
Title: -
Shares: 5,044
Price/Share: $111.10
Value: $560,388.40
Shares Owned: 3,942
Relationship: Director
Ownership: Direct
2026-03-11Sale
Owner: Roberts, David B
Title: President and Director
Shares: 3,312
Price/Share: $107.68
Value: $356,601.70
Shares Owned: 14,667
Relationship: Director,Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
93.30%
Inst. Shares: 21,273,703
Shares Outstanding: 22,801,000
2025-12-31
92.59%
Inst. Shares: 20,961,491
Shares Outstanding: 22,638,000
2025-09-30
89.11%
Inst. Shares: 20,192,465
Shares Outstanding: 22,660,000
2025-06-30
89.82%
Inst. Shares: 20,311,321
Shares Outstanding: 22,614,000
2025-03-31
91.02%
Inst. Shares: 20,543,858
Shares Outstanding: 22,570,000

LEMAITRE VASCULAR INC (LMAT) — SEC Financial Statements & Analysis

LEMAITRE VASCULAR INC (LMAT) is a surgical & medical instruments & apparatus company. LEMAITRE VASCULAR INC trades on Nasdaq as: LMAT. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), LEMAITRE VASCULAR INC reported a 11.85% year-over-year revenue growth, a Gross Profit Margin of 72.90% (TTM), a Debt-to-Equity ratio of 0.52x, a Price-to-Sales (P/S) ratio of 8.33x (TTM), a Price-to-Book (P/B) ratio of 5.20x (TTM), at a market cap of $2.19B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
11.85%
Gross Profit Margin TTM
72.90%
Debt To Equity
0.52x
P/S TTM
8.33x
P/B TTM
5.20x
Market Cap
$2.19B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is LEMAITRE VASCULAR INC in?

LEMAITRE VASCULAR INC (LMAT) operates in the Surgical & Medical Instruments & Apparatus industry.

What is LMAT's market cap?

LEMAITRE VASCULAR INC (LMAT) has a market capitalization of $2.19B as of 2026-06-30.

What is LMAT's P/E ratio?

LEMAITRE VASCULAR INC (LMAT)'s trailing twelve month P/E ratio is 33.30x as of 2026-06-30.

What exchange does LMAT trade on?

LEMAITRE VASCULAR INC (LMAT) trades on the Nasdaq.

Wall Street's data.
Main Street's price.